You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-TNFRSF10D (TNFRSF10D) Antibodies

Full name:
anti-Tumor Necrosis Factor Receptor Superfamily, Member 10d, Decoy with Truncated Death Domain Antibodies (TNFRSF10D)
On www.antibodies-online.com are 141 Tumor Necrosis Factor Receptor Superfamily, Member 10d, Decoy with Truncated Death Domain (TNFRSF10D) Antibodies from 23 different suppliers available. Additionally we are shipping TNFRSF10D Proteins (16) and TNFRSF10D Kits (8) and many more products for this protein. A total of 175 TNFRSF10D products are currently listed.
Synonyms:
CD264, DCR2, TNFRSF10D, TRAIL-R4, TRAILR4, TRUNDD
list all antibodies Gene Name GeneID UniProt
TNFRSF10D 8793 Q9UBN6
TNFRSF10D    
TNFRSF10D    

Show all species

Show all synonyms

Most Popular Reactivities for anti-TNFRSF10D (TNFRSF10D) Antibodies

Select your species and application

anti-Human TNFRSF10D Antibodies:

anti-Mouse (Murine) TNFRSF10D Antibodies:

anti-Rat (Rattus) TNFRSF10D Antibodies:

All available anti-TNFRSF10D Antibodies

Go to our pre-filtered search.

Top referenced anti-TNFRSF10D Antibodies

  1. Human Polyclonal TNFRSF10D Primary Antibody for EIA, IF - ABIN499724 : Marsters, Sheridan, Pitti, Huang, Skubatch, Baldwin, Yuan, Gurney, Goddard, Godowski, Ashkenazi: A novel receptor for Apo2L/TRAIL contains a truncated death domain. in Current biology : CB 1998 (PubMed)
    Show all 6 references for ABIN499724

  2. Human Monoclonal TNFRSF10D Primary Antibody for FACS - ABIN487316 : Mérino, Lalaoui, Morizot, Schneider, Solary, Micheau: Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2. in Molecular and cellular biology 2006 (PubMed)
    Show all 5 references for ABIN487316

  3. Human Monoclonal TNFRSF10D Primary Antibody for FACS - ABIN238513 : Deligezer, Dalay: Expression of the TRAIL receptors in blood mononuclear cells in leukemia. in Pathology oncology research : POR 2007 (PubMed)
    Show all 5 references for ABIN238513

  4. Human Monoclonal TNFRSF10D Primary Antibody for FACS - ABIN487317 : Clancy, Mruk, Archer, Woelfel, Mongkolsapaya, Screaton, Lenardo, Chan: Preligand assembly domain-mediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosis. in Proceedings of the National Academy of Sciences of the United States of America 2005 (PubMed)
    Show all 5 references for ABIN487317

  5. Human Monoclonal TNFRSF10D Primary Antibody for ICC, FACS - ABIN1169231 : Washburn, Weigand, Grosse-Wilde, Janke, Stahl, Rieser, Sprick, Schirrmacher, Walczak: TNF-related apoptosis-inducing ligand mediates tumoricidal activity of human monocytes stimulated by Newcastle disease virus. in Journal of immunology (Baltimore, Md. : 1950) 2003 (PubMed)
    Show all 3 references for ABIN1169231

  6. Human Polyclonal TNFRSF10D Primary Antibody for EIA, FACS - ABIN951252 : Pei, Wu, Lin: Hypoxia-induced decoy receptor 2 gene expression is regulated via a hypoxia-inducible factor 1alpha-mediated mechanism. in Biochemical and biophysical research communications 2010 (PubMed)
    Show all 2 references for ABIN951252

  7. Human Monoclonal TNFRSF10D Primary Antibody for FACS - ABIN1106174 : Baritaki, Katsman, Chatterjee, Yeung, Spandidos, Bonavida: Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulation. in Journal of immunology (Baltimore, Md. : 1950) 2007 (PubMed)
    Show all 2 references for ABIN1106174

More Antibodies against TNFRSF10D Interaction Partners

Human Tumor Necrosis Factor Receptor Superfamily, Member 10d, Decoy with Truncated Death Domain (TNFRSF10D) interaction partners

  1. Results identified epigenetic inactivation of TNFRSF10C (show TNFRSF10C Antibodies) and TNFRSF10D in majority of cervical cancer cases.

  2. This study identified TNFRSF10D DNA methylation (show HELLS Antibodies) status as an independent prognostic biomarker for relapse-free survival and overall mortality in non-metastatic melanoma patients.

  3. The membrane expression of the TRAIL receptors DR4 (show HLADRB4 Antibodies), DR5 (show TNFRSF10B Antibodies), DcR1 (show TNFRSF10C Antibodies) and DcR2 (show CCR6 Antibodies) is greater in normal endometrium than endometrioid adenocarcinoma (EAC (show CYLD Antibodies)). The level of the receptors in EAC (show CYLD Antibodies) is not dependent on grading and staging and does not predict survival.

  4. the results presented here claim for a relevant impact of aberrant methylation of decoy receptors in melanoma and allow to understand how the silencing of DcR1 (show TNFRSF10C Antibodies) and DcR2 (show CCR6 Antibodies) is related to melanomagenesis.

  5. transcript levels of UCHL1 (show UCHL1 Antibodies), COL1A2 (show COL1A2 Antibodies), THBS1 (show THBS1 Antibodies) and TNFRSF10D were inversely correlated with promoter methylation

  6. TRAIL receptor-4 expression profiles on T cells might be important in revelation of rheumatoid arthritis pathogenesis.

  7. ANT2 (show SLC25A5 Antibodies) shRNA treatment sensitized MCF7, T47 D, and BT474 cells to TRAIL-induced apoptosis by up-regulating the expression of TRAIL death receptors 4 and 5 (DR4 (show HLADRB4 Antibodies) and DR5 (show TNFRSF10B Antibodies)) and down-regulating the TRAIL decoy receptor 2 (DcR2).

  8. these results demonstrated that hypoxia-inducible factor 1alpha played a crucial role in regulating the transcription of DcR2 (show CCR6 Antibodies).

  9. TNF-related apoptosis-inducing ligand (TRAIL (show TNFSF10 Antibodies)) is not constitutively expressed in the human brain, whereas both apoptosis-mediating and apoptosis-blocking TRAIL receptors are found on neurons, astrocytes, and oligodendrocytes

  10. Enhanced expression of DcR2 (show CCR6 Antibodies) promotes peripheral blood eosinophil survival in the airways of allergic asthmatics following segmental antigen challenge.

TNFRSF10D Antigen Profile

Antigen Summary

The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor contains an extracellular TRAIL-binding domain, a transmembrane domain, and a truncated cytoplamic death domain. This receptor does not induce apoptosis, and has been shown to play an inhibitory role in TRAIL-induced cell apoptosis.

Alternative names and synonyms associated with TNFRSF10D

  • tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain (TNFRSF10D) antibody
  • CD264 antibody
  • DCR2 antibody
  • TNFRSF10D antibody
  • TRAIL-R4 antibody
  • TRAILR4 antibody
  • TRUNDD antibody

Protein level used designations for TNFRSF10D

tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain , TNF receptor-related receptor for TRAIL , TNF-related apoptosis-inducing ligand receptor 4 , TRAIL receptor 4 , TRAIL receptor with a truncated death domain , decoy receptor 2 , tumor necrosis factor receptor superfamily member 10D

GENE ID SPECIES
472715 Pan troglodytes
716901 Macaca mulatta
8793 Homo sapiens
Selected quality suppliers for anti-TNFRSF10D (TNFRSF10D) Antibodies
Did you look for something else?